KIFC3 promotes proliferation, migration and invasion of esophageal squamous cell carcinoma cells by activating EMT and β-catenin signaling

doi:10.4251/wjgo.v14.i7.1239

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3328)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series.

Item

Count

PDF

152

WORD

HTML

1827

Figures (1-6)

406

Sum=2438

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

286

Download

604

Sum=890

Jul 15, 2022 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Jul 15, 2022; 14(7): 1239-1251
Published online Jul 15, 2022. doi: 10.4251/wjgo.v14.i7.1239

Full Size Figure Download Figure

Figure 4 KIFC3 knockdown inhibits the growth of ESCC cells in vivo. A: Images of tumors formed in nude mice; B: Volume curves of xenograft tumors; C: Weight of xenograft tumors; D: Immunohistochemistry showing that KIFC3 knockdown inhibits the expression of Ki-67, scale bar: 20 μm. ^aP < 0.05 versus the control group. ESCC: Esophageal squamous cell carcinoma; KIFC3: Kinesin family member C3.

Citation: Hao WW, Xu F. KIFC3 promotes proliferation, migration and invasion of esophageal squamous cell carcinoma cells by activating EMT and β-catenin signaling. World J Gastrointest Oncol 2022; 14(7): 1239-1251
URL: https://www.wjgnet.com/1948-5204/full/v14/i7/1239.htm
DOI: https://dx.doi.org/10.4251/wjgo.v14.i7.1239